Related Experiment Videos
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma
A Falchetti1, L Becherini, V Martineti
1Department of Clinical Physiopathology, University of Florence, Florence, Italy.
Biochemical and Biophysical Research Communications
|November 5, 1999
Summary
Telomerase activity, detected by the TRAP assay, was found only in malignant parathyroid tumors. This suggests telomerase expression may help diagnose parathyroid cancer and predict its aggressive potential.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Telomerase is active in germ cells, stem cells, and many malignant tumors.
- Investigating molecular markers beyond Rb gene inactivation is crucial for diagnosing parathyroid tumors.
Purpose of the Study:
- To investigate telomerase activity in various human parathyroid tissues.
- To determine if telomerase can aid in diagnosing parathyroid malignancy.
Main Methods:
- Telomerase activity was assessed using the TRAP assay.
- Tissues analyzed included normal, hyperplastic, adenomatous, and carcinomatous parathyroid glands, as well as primary cell cultures and metastatic tissue.
Main Results:
- Only malignant parathyroid glands and metastatic tissue showed positive TRAP assay results.
- Telomerase activity was absent in normal, hyperplastic, and adenomatous parathyroid tissues.
Conclusions:
- Telomerase expression is associated with the aggressive phenotype of parathyroid epithelial cells.
- The TRAP assay could be a valuable tool for the molecular diagnosis of parathyroid carcinoma.